News | Radiation Therapy | October 19, 2016

IBA and Philips Launch Patient-centric Ambient Experience Solution for Proton Therapy

Ambient Experience uses modern technology and design to create a more comfortable and soothing experience for patients and staff during proton therapy

IBA, Philips, Ambient Experience, proton therapy, Proteus One, Proteus Plus, ASTRO 2016

October 19, 2016 — IBA (Ion Beam Applications SA) and Philips announced in September the launch of a dedicated patient-centric Ambient Experience solution for the proton therapy gantry of IBA’s Proteus Plus proton therapy solution. The announcement makes the Philips solution now available for both Proteus One and Proteus Plus.

Designed and engineered by Philips, Ambient Experience is an interactive, patient-focused healthcare environment that uses modern technology and people-centric design to create a more comfortable and soothing experience for patients and staff, helping to improve workflows and increase operational effectiveness. Implemented in IBA’s proton therapy gantries, patients are able to select their preferred theme, light, sound and video prior to undergoing treatment. By enhancing the clinical environment, Philips’ Ambient Experience improves patient comfort and staff experience and satisfaction. In 2014, Philips received an international Red Dot Award for product design for its dedicated Proteus One Ambient Experience solution.

The new Ambient Experience development is part of a broader collaboration between the two companies that also includes the joint marketing and sales of IBA’s proton therapy solutions and Philips’ imaging and clinical informatics solutions.

"The Philips Ambient Experience is one of the many differentiators of the Proteus One solution,” said Lane Rosen, M.D., at Willis-Knighton Cancer Center in Shreveport, La., the first IBA center to use Philips Ambient Experience. “Patients have the ability to change their color themes, music and video. Our patients enjoy the experience as it helps them to relax during treatment and remain still. The Ambient Experience atmosphere is calming for the staff as well as the therapist for this most meticulous of treatments."

"Cancer treatment can be a frightening experience, so making the environment as pleasant as possible is essential to reduce stress,” said Prof. Karol Sikora, chief medical officer of U.K.-based Proton Partners International, which is currently building three proton therapy centers. “We believe lighting, design and music will help to create a relaxing and soothing experience. And it will make our staff more relaxed too, by creating an atmosphere of greater empathy. We look forward to operating our first center with Philips Ambient Experience next year in Newport, Wales."
 
In 2016, IBA and Philips plan to equip four additional rooms in the United States: three Proteus Plus rooms in the Miami Cancer Institute, and one Proteus One at the Beaumont Hospital in Royal Oak, Mich. In addition, Philips and IBA have a pipeline of rooms to be equipped with Philips Ambient Experience features in the U.K., Middle East, U.S. and Taiwan.

For more information: www.iba-worldwide.com, www.usa.philips.com/healthcare

Related Content

A special issue of the Journal of Medical Imaging and Radiation Sciences features stories about the interpersonal skills beyond the technical aspects to care for and guide patients through medical imaging and radiation therapy procedures

Image courtesy of Canon

News | Patient Engagement | August 11, 2020
August 11, 2020 — "I went into the MRI
Global radiotherapy market revenue is set to expand from $7,222.4 million in 2019 to $17,194.4 million by 2030, at an 8.4% CAGR between 2020 and 2030, the key factor driving the market growth is the increasing number of cancer cases, according to the report published by P&S Intelligence.

Image courtesy of Elekta

News | Radiation Therapy | August 06, 2020
August 6, 2020 — Global ...
Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly welcomes Siemens Healthineers AG’s acquisition of a 100 percent stake in Varian Medical Systems, Inc., a U.S. company active in the area of cancer research and therapy.

Getty Images

News | Radiology Business | August 03, 2020
August 3, 2020 — Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly wel
JAMA Oncol. Published online  July 30, 2020. doi:10.1001/jamaoncol.2020.2783

Table 1. JAMA Oncol. Published online  July 30, 2020. doi:10.1001/jamaoncol.2020.2783

News | Coronavirus (COVID-19) | July 31, 2020
July 31, 2020 — An article published in JAMA...
It has been estimated that the overwhelming focus on COVID-19 could cause up to 35,000 excess cancer deaths in the UK during the next 12 months, and  Zegami, the Oxford University data visualization spin-out which has worked on several projects focused on the detection, diagnosis, or management of cancer, is calling for greater use of technology to speed up the process of diagnosis and treatment.

Getty Images

News | Radiation Oncology | July 29, 2020
July 29, 2020 — It has been estimated that the overwhelming focus on...
In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study.  http://jnm.snmjournals.org/content/early/2020/07/16/jnumed.120.249748.full.pdf+html

In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study.

 

News | Coronavirus (COVID-19) | July 22, 2020 | Dave Fornell, Editor
July 22, 2020 — One of the first studies has been published that looks at the use of...
World's largest radiation oncology meeting will offer full conference on interactive platform October 25-28, 2020
News | ASTRO | July 09, 2020
July 9, 2020 — Registration opens today for the American Society for Radiation Oncology's (...
Radiotherapy has been used to treat cancers for more than a century and continues to be utilized in cancer treatment plans today. Since the introduction of radiotherapy, clinicians have been working tirelessly to further refine treatments to better target cancer.
Feature | Radiation Therapy | July 06, 2020 | By Yves Archambault
Everything has room for improvement, right? Right. When it comes to cancer care, it is no different.